Key points are not available for this paper at this time.
Despite aggressive resection and combined modality adjuvant treatment, most GBMs recur. Treatments, such as TTFields, drugs to target molecular receptors, and immunotherapy, are promising new options.
Mary E. Davis (Mon,) studied this question.